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Effects of Arsenic Cell Metabolism and
Cell Proliferation: Cytogenetic
and Biochemical Studies
by Johannes Petres,* Diethart Baron,t
and Manfred Hagedorn*
Chromosome analysis oflymphocytes from patients who had been exposed to arsenic showed frequent
structural and numerical aberrations, even with an interval of decades since the last exposure.
The in vitro addition of sodium arsenate induced the same chromosome changes-even to extreme of
chromosome pulverizations-upon lymphocyte cultures from healthy subjects. Radioactive incorporation
studies showed that arsenate was able to inhibit dose-dependently the incorporation of radioactively
labeled nucleotide in RNA and DNA. Beyond that, arsenic blocked the cells in the S- and G2-phase.
A general explanation for the inhibitory effect of inorganic arsenic on cell metabolism is the known
strong affinity of arsenic to enzymes, especially to those containing sulfhydryl groups.
Introduction
The well-known carcinogenic effect of inorganic
arsenic compounds indicates that these substances
can directly or indirectly alter the distribution or
composition of "genetic" material localized in the
chromosome and thereby provide a prerequisite for
the origin of atypical cell populations (1, 2). We
found massive lesions ofthe cellular nucleus-even
",chromosome pulverizations''-after in vitro
exposure to arsenic in lymphocyte cultures taken
from subjects not exposed to arsenic (3). For this
reason we studied the problem of whether the lym-
phocytes from persons who had previously come
into contact with arsenic, either in their profession
(vine-growers) or for therapeutic reasons (e.g.,
psoriasis) demonstrated corresponding chromo-
somal changes.
Supplementary experiments with in vitro
administration of arsenate in cultured lymphocytes
should explain to what extent these chromosome
aberrations are dose-dependent and to what extent
arsenic is capable of altering nucleic acid
metabolism.
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Materials and Methods
Cytogenetic Studies
Test subjects were 62 patients of the University
of Freiburg (i. Br.) Dermatological Clinic. Of these
patients, 31 had a history of extensive arsenic con-
tact. In some cases, the last arsenic exposure was
more than 30 years previously. The test group con-
sisted of 14 psoriasis patients and 17 vine-growers.
All displayed typical arsenic hyperkeratosis on the
palms of their hands and the soles of their feet (4).
Several of the patients already had arsenic-induced
skin carcinomas excised. The control group (31
subjects) consisted of 14 psoriasis patients and 17
healthy volunteers without traceable history of ar-
senic contact.
For the chromosome analysis phytohemaggluti-
nin (PHA)-stimulated lymphocyte cultures were
prepared according to Moorhead et al. (5). Produc-
tion ofair-dried preparations was followed by stain-
ing with orcein diluted in acetic acid (6).
Radioactive Incorporation Test
The preparation of the PHA-stimulated lympho-
cyte cultures was carried out by use of the tech-
niques described by Moorhead et al. (5). The prep-
223aration of the culture material for autoradiography
and liquid scintillation counting has already been
described in detail by Petres et al. (7, 8). To the
individual lymphocyte cultures from volunteers not
exposed to arsenic sodium arsenate was added in
concentrations between 0.05 and 100 ,ug/ml culture
medium 24 hr before stopping the culture. Cultures
from the same subjects prepared in a parallel man-
ner but without the addition of arsenic served as
controls.
DNA Cytophotometry
Suspended lymphocytes exposed in vitro to
sodium arsenate (0.1 to 500 ,ug Na.,HAsO,/ml cul-
ture medium) were smeared on a microscopic slide,
air-dried, and mounted. One series of preparations
was stained with gallocyanin chromatalaun (9).
Subsequently, the same preparation was covered
with Kodak AR 10 stripping film and exposed for 10
days.
DNA in nonlabeled cells was determined
cytophotometrically with an integrating microden-
sitometer (Barr and Stroud, Glasgow); measure-
ment conditions: objective 100 x, extinction level
0.75, magnification stage 5, wavelength 575 nm; 50
cells from each preparation were measured.
Results
Cytogenetic Studies
The frequency of chromosome aberrations
among our subjects in the arsenic-exposed subject
group was significantly above that of the controls.
This difference is especially evident in chromatid
and chromosome aberrations, which exhibit re-
markably low spontaneous frequency (Table 1).
The number ofbreaks per mitosis amounted to 0.07
in the arsenic-exposed group and only 0.002 in the
controls.
Table 1. Chromosome aberrations in 31 chronic arsenic patients
and 31 healthysubjects.
No. ofaberrations
Arsenical
exposure Control
Typeofabnormality group group
Secondary constrictions 52 13
Achromatic lesions 29 3
Gaps 58 9
Chromatid breaks 34 1
Acentricfragments 39 2
Dicentric chromosomes 3 0
Numberofmitoses 1121 1247
ferentiated the arsenic-exposed group from the con-
trols. The aneuploidy is constantly caused by
chromosome "deficiency" (Fig. 1). Our results con-
firm those of our preliminary studies in 1970 (11).
Radioactive Incorporation Test
The experiments show that even relatively low
dosages of arsenic cause mild to severe impairment
of nuclear division (Figs. 2 and 3). It is remarkable
that even "pulverized" chromosomes are able to
incorporate in vitro the radioactively labeled
thymidine as precursor of DNA (Fig. 4).
Autoradiographic experiments have further
shown that the incorporation of :3H-labeled
thymidine in the DNA above a dosage of 0.1 g
sodium arsenate/ml culture medium is reduced in
dose dependency compared with the control prep-
arations. The incorporation of 3H-uridine in the
RNA is less clearly inhibited by arsenic (Fig. 5).
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FIGURE 1. Frequency of aneuploidy mitosis (expressed as per-
cent). Comparison ofarsenic-exposed patients with the con-
trol subjects. Expected values from Court-Brown et al. (10).
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In addition, structural, multiple numerical
chromosome aberrations were found which dif-
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gm FIGUR 3. Preparations showing (a) metaphase of lymphocyte
M culture after reaction with arsenic (10 0 .g Na2HAsO.dml
culture medium) without stripping film; (b) slight tritium-
thymidine-labeling of the above chromosome pulverization.
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FIGURE 4.Metaphase of lymphocyte culture after 48-hr reaction
of 1.0 ,zg Na2HAsOJml tetraploid set of chromosomes.
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material from arsenic-treated cell cultures showed
that arsenic inhibits the dose-dependent incorpora-
tion ofexogenously added 14C-labeled nucleoside in
both the DNA as well as the RNA (Fig. 5).
DNA Cytophotometry
DNA measurements of PHA-stimulated lym-
phocytes demonstrated that under increased arse-
nic concentrations hyperdiploid cells decreased,
i.e., in cells which are in the synthesis and G.,
phase. At the same time, an increase in hypodiploid
cells was ascertained (Fig. 6).
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FIGURE 5. Graphic presentation of the influence of increasing
Na2HAsO, concentrations upon the incorporation of
'4C-thymidine and '4C-uridine (scintillation measurements)
and 'H-thymidine + :3H-uridine (autoradiography) in DNA
and RNA ofcultivated human lymphocytes. Control cultures
without arsenic additive = 100% (average value per arsenic
concentration and control from duplicate analysis of every
five to seven cultures from different subjects).
Discussion
The chromosomal aberration rate we observed in
vinegrowers and psoriasis patients who had been
previously exposed to arsenic was significantly
above the value for the control group and above the
value reported by Court-Brown et al. (10) for the
frequency of occurrence in an average population.
It must, therefore, be assumed that the increased
number of aberrations is directly related to the his-
tory of arsenic contacts (11).
The mechanism which leads to these
chromosomal changes is not yet entirely clear. It is,
however, presumable that arsenic acts as an imped-
iment to diverse enzyme-systems which interfere
with nucleic acid metabolism, especially by interac-
tion with those enzymes which contain sulfhydryl
groups (8, 12-14).
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FIGURE 6. Frequency distribution of the DNA-containing
RNA-stimulated lymphocytes in relative units (AE) after the
reaction with various Na2HAsO, concentrations (in ,ug/ml
culture medium). Measurements of unlabeled cells.
The cytophotometrically proven arsenic-pro-
duced blocking of lymphocytes in the S- or
G.,-phase finds its cytogenetic correlation in the
more frequent appearance of endoreduplications,
i.e., cells with tetraploid chromosome sets (Fig. 3).
A further site of activity by arsenic on cell
metabolism could be that arsenic, as in the
mechanism of decoupling of the substrate chain
phosphorylation, either incorrectly builds into the
nucleotide chains during nucleic acid synthesis or in
higher concentrations competitively inhibits the in-
corporation of phosphorus. The inhibition would
then be dependent upon the arsenic phosphorus
ratio.
The results of our radioactive incorporation
studies are comparable with those of Sibatani (17),
who proved that inorganic arsenic compounds
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labeled phosphorus into the nucleic acid. It is con-
ceivable that the messenger RNA is already altered
during its formation and delivers faulty information
to the sites of protein synthesis, e.g., enzymes of
replication, repair, and formation of precursors
(18-23). Although not statistically significant, the
different inhibition-curve progressions ofthymidine
and uridine incorporation indicate that the DNA-
polymerase is more severely inhibited than the
RNA-polymerase (8). These reactions could pro-
vide an explanation for the observed chromosome
aberrations both in vivo and in vitro (24, 25). If
primary cells are damaged as a result of contact to
arsenic and subsequently survive, they could then
become the stem cells (26) for a pathologic popula-
tion still detectable many years later in the form of
aneuploid cells or cells with marked chromosome
anomalies in chronic arsenic intoxication (11).
This impairment mechanism has an effect not
only upon lymphocytes but also other cell systems
which in chronic arsenic patients manifest them-
selves in more frequent neoplasias ofthe skin, liver,
and bronchi (27, 28). The few leukoses (1) can be
explained by a lower sensitivity of the hema-
topoietic system to the mutagenic agent arsenic.
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